Brooks Laboratories will be reviewing their fiscal year 2026 financial results on May 29, 2026. From April 1st until the announcement, there will be a trading window closure for directors and insiders, reopening 48 hours post-result declaration.

Brooks Labs has called off its planned merger with Brooks Steriscience, in a move intended to safeguard the interests of its shareholders. This action contradicts previous approval from the stock exchange.

Brooks Steriscience has abandoned their planned merger, despite previous approvals from the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). The joint venture's board has decided not to proceed with the current merger proposal.

Brooks Labs saw a significant drop today, hitting its lower circuit at ₹49.93 on May 8, 2026. The selling pressure was high, with no buyers in sight, causing the stock to freeze.